Idexx Laboratories IDXX
NASDAQ IDXX
$518.00 +4.86 (+0.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Idexx Laboratories (IDXX) Selling, General & Administrative (2009 - 2026)

Updated

Idexx Laboratories (IDXX) reported Selling, General & Administrative of $116.82 million for Q2 2026, up 18.4% from $98.68 million a year earlier but down 1.9% from the prior quarter.

Analysis

Idexx Laboratories (IDXX) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Idexx Laboratories' Selling, General & Administrative came in at $450.48 million, up 17.5% year-over-year; for FY2025, it came in at $404.79 million, down 8.5% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $442.29 million in FY2024 (+31.7%), $335.83 million in FY2023 (+2.9%), $326.25 million in FY2022 (+5.4%) and $309.66 million in FY2021 (+2.9%).
  • Five-year quarterly Selling, General & Administrative spans a low of $70.1 million in Q1 2023 and a high of $157.24 million in Q2 2024.
  • Year over year, Selling, General & Administrative has now increased in each of the last four quarters, with growth averaging 6.6% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q2 2024 (growth of 75.4%); the low point was Q2 2025 (a decline of 37.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $119.12 million (Q1 2026), $108.62 million (Q4 2025) and $105.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 6.43 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 3.63 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -5.65 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 1.92 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 3.41 Bn
10 Idexx Laboratories 40.86 Bn 40.07 Bn 779.09 Mn 116.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 116.82 Mn
Mar 31, 2026 119.12 Mn
Dec 31, 2025 108.62 Mn
Sep 30, 2025 105.94 Mn
Jun 30, 2025 98.68 Mn
Mar 31, 2025 91.56 Mn
Dec 31, 2024 101.14 Mn
Sep 30, 2024 91.89 Mn
Jun 30, 2024 157.24 Mn
Mar 31, 2024 92.02 Mn
Dec 31, 2023 87.02 Mn
Sep 30, 2023 89.03 Mn
Jun 30, 2023 89.67 Mn
Mar 31, 2023 70.10 Mn
Dec 31, 2022 83.05 Mn
Sep 30, 2022 83.76 Mn
Jun 30, 2022 81.49 Mn
Mar 31, 2022 77.95 Mn
Dec 31, 2021 83.47 Mn
Sep 30, 2021 82.10 Mn
API Access

Idexx Laboratories Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IDXX&period=max&api_key=YOUR_API_KEY